MedPath

Effect Of Biomechanical Stimulation On Skeletal Health In Adolescent And Young Women With Anorexia Nervosa

Not Applicable
Completed
Conditions
Anorexia Nervosa
Interventions
Device: Low-magnitude mechanical stimulation platform
Registration Number
NCT01100567
Lead Sponsor
Boston Children's Hospital
Brief Summary

This study will evaluate the effects of a novel, non-pharmacologic intervention for the prevention of deleterious changes in bone density and strength in adolescents with anorexia nervosa (AN), a disease commonly treated with extended periods of bed rest and immobilization. The primary focus of the trial is to conduct a prospective short-term intervention to prevent an uncoupling of bone turnover in inpatients hospitalized for AN, and to determine the long-term effects of a biomechanical intervention on skeletal health in ambulatory adolescents with AN.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
101
Inclusion Criteria
  • Age 11-25 years
  • Diagnosis of anorexia nervosa based on DSM-IV criteria
  • Female gender
  • English-speaking
Exclusion Criteria
  • • Concomitant chronic diseases which affect bone health, such as cystic fibrosis, inflammatory bowel disease, celiac disease, renal disease, or diabetes mellitus

    • Use of medications known to affect bone metabolism in the last 3 months, such as:

      • Glucocorticoid therapy (including inhaled steroids)
      • Anticonvulsants
      • Combined estrogen/progestin contraceptive agents (oral contraceptive pills)
    • Depot medroxyprogesterone (Depo-Provera) use in the last 12 months

    • Current pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low-magnitude mechanical stimulationLow-magnitude mechanical stimulation platformRandomized to stand on LMMS platform 10 minutes/daily
Placebo platformLow-magnitude mechanical stimulation platformRandomized to stand on placebo platform for 10 minutes/day
Primary Outcome Measures
NameTimeMethod
Change From Baseline in C-telopeptidesBaseline to 5 days
Secondary Outcome Measures
NameTimeMethod
Change From Baseline in Bone Specific Alkaline Phosphatasebaseline to 5 days

Trial Locations

Locations (1)

Children's Hospital Boston

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath